|
Status |
Public on Apr 17, 2009 |
Title |
Expression data from A2780 (cisplatin-sensitive) and Round5 A2780 (cisplatin-resistant) cell lines. |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Cisplatin and carboplatin are the primary first-line therapies for the treatment of ovarian cancer. However, resistance to these platinum-based drugs occurs in the large majority of initially responsive tumors, subsequently resulting in a poor long-term prognosis. To model the onset of drug resistance, we measured gene expression alterations associated with cisplatin resistance.
|
|
|
Overall design |
We treated clonally derived, drug-sensitive A2780 epithelial ovarian cancer cells with increasing concentrations of cisplatin. After 5 cycles of drug selection, the isogenic drug-sensitive (parental A2780) and -resistant (Round5 A2780) cell lines were subjected to mRNA expression microarray analyses.
|
|
|
Contributor(s) |
Li M, Nephew KP |
Citation(s) |
19505326 |
|
Submission date |
Mar 24, 2009 |
Last update date |
Mar 25, 2019 |
Contact name |
Meng Li |
E-mail(s) |
menli@indiana.edu
|
Organization name |
Indiana University
|
Department |
Medical Sciences
|
Street address |
1001 E 3rd Street
|
City |
Bloomington |
State/province |
IN |
ZIP/Postal code |
47405 |
Country |
USA |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (10)
|
GSM385721 |
parental A2780 (cisplatin-sensitive), biological rep1 |
GSM385722 |
parental A2780 (cisplatin-sensitive), biological rep2 |
GSM385723 |
parental A2780 (cisplatin-sensitive), biological rep3 |
GSM385724 |
parental A2780 (cisplatin-sensitive), biological rep4 |
GSM385725 |
parental A2780 (cisplatin-sensitive), biological rep5 |
GSM385726 |
Round5 A2780 (cisplatin-resistant), biological rep1 |
GSM385727 |
Round5 A2780 (cisplatin-resistant), biological rep2 |
GSM385728 |
Round5 A2780 (cisplatin-resistant), biological rep3 |
GSM385729 |
Round5 A2780 (cisplatin-resistant), biological rep4 |
GSM385730 |
Round5 A2780 (cisplatin-resistant), biological rep5 |
|
This SubSeries is part of SuperSeries: |
GSE15709 |
Expression and methylation data from A2780 (cisplatin-sensitive) and Round5 A2780 (cisplatin-resistant) cell lines |
|
Relations |
BioProject |
PRJNA123257 |